Last updated: July 23, 2026

Does Aetna Cover Anxiety Treatment in Delaware? A 2026 Guide

If you have Aetna health insurance in Delaware and you or a loved one is struggling with an anxiety disorder, understanding your coverage for therapy, medication, and telehealth visits may save you significant time and money. Aetna is a major commercial insurer in Delaware, and its pharmacy benefits are administered through CVS/Caremark. This guide explains how Delaware’s mental health parity law applies to anxiety treatment, what CVS/Caremark’s formulary typically covers, which medications require prior authorization, and how Delaware’s Electronic Prescribing of Controlled Substances (EPCS) rules affect your prescriptions.

Ready to connect with a licensed anxiety provider who accepts Aetna? See if your Aetna plan may cover anxiety treatment at Klarity →

Key facts at a glance

• Insurer: Aetna (Delaware commercial and Medicare Advantage plans)
• PBM: CVS/Caremark
• State parity law: Del. Code Ann. tit. 18, § 3343 (anxiety disorders are covered mental health conditions under MHPAEA-aligned parity)
• Delaware EPCS: Benzodiazepines (alprazolam, clonazepam, lorazepam, diazepam) = Schedule IV = EPCS REQUIRED. Pregabalin (Lyrica) = Schedule V = EPCS REQUIRED. SSRIs, SNRIs, buspirone, hydroxyzine, propranolol = non-scheduled = EPCS inapplicable.
• PA requirement: Generic SSRIs/SNRIs typically no PA; benzodiazepines and pregabalin require PA + step therapy + quantity limits
• Aetna member services: 1-800-872-3862
• CVS/Caremark: 1-800-552-8159
• Delaware Department of Insurance: 1-302-674-7300

Does Aetna Cover Anxiety Treatment in Delaware?

Aetna’s commercial health plans in Delaware typically include behavioral health benefits that may cover a range of anxiety disorder treatments. Covered services often include:

• Psychiatric evaluation and diagnosis. Initial assessment by a licensed psychiatrist or psychiatric nurse practitioner
• Outpatient therapy. Individual psychotherapy, cognitive behavioral therapy (CBT), and other evidence-based modalities
• Telehealth visits. Video and phone consultations with behavioral health providers, including for anxiety medication management
• Intensive outpatient programs (IOP). Structured programs for moderate-to-severe anxiety disorders
• Prescription medications. SSRIs, SNRIs, buspirone, hydroxyzine, and other FDA-approved anxiety medications through the CVS/Caremark formulary
• Preventive screenings. Anxiety disorder screening (e.g., GAD-7) at no cost-sharing under the ACA for non-grandfathered plans

Coverage details vary significantly by plan type (HMO, PPO, EPO), employer group, and whether the plan is fully insured or self-funded under ERISA. Always call the member services number on your Aetna ID card or visit Aetna’s website to verify your specific benefits before scheduling care.

Delaware Mental Health Parity Law: Del. Code Ann. tit. 18, § 3343

Delaware’s mental health parity statute, Del. Code Ann. tit. 18, § 3343, requires that state-regulated commercial health insurers, including most Aetna individual and fully insured group plans sold in Delaware, provide mental health and substance use disorder benefits that are no more restrictive than comparable medical/surgical benefits. The statute aligns Delaware law with the federal Mental Health Parity and Addiction Equity Act (MHPAEA). Anxiety disorders are recognized mental health conditions under the DSM-5 and fall squarely within these parity protections.

In practical terms, § 3343 means:

• Aetna may not impose higher copays, stricter prior authorization criteria, or lower visit limits for anxiety treatment than it does for comparable physical health conditions
• Quantitative treatment limitations (visit caps, day limits) and non-quantitative treatment limitations (medical necessity criteria, step therapy protocols) for anxiety care must be comparable to those for medical/surgical benefits
• Cost-sharing (copays, deductibles, coinsurance) for anxiety treatment must be no more restrictive than for analogous medical conditions

Important: ERISA self-funded employer plans are governed by the federal MHPAEA, not § 3343. Self-funded plan members should contact the U.S. Department of Labor EBSA at 1-866-444-3272 for parity complaints.

If you believe Aetna is applying more restrictive limits to your anxiety treatment than to comparable medical benefits, you may file a parity complaint with the Delaware Department of Insurance at 1-302-674-7300.

Aetna’s Behavioral Health Benefits for Anxiety in Delaware

Aetna manages behavioral health benefits through its Behavioral Health division. For Delaware members with anxiety disorders, benefits may include:

Outpatient Mental Health Services

Outpatient therapy visits (in-person or telehealth) for anxiety disorders such as generalized anxiety disorder (GAD), panic disorder, social anxiety disorder, PTSD, OCD, and specific phobias are typically covered subject to your plan’s deductible and copay structure. In-network providers generally result in lower cost-sharing than out-of-network providers.

Telehealth Anxiety Treatment

Aetna’s telehealth benefits have expanded significantly. Many Aetna plans in Delaware cover telehealth mental health visits, including video consultations for anxiety evaluation, therapy, and medication management, at the same cost-sharing as in-person visits. Telehealth platforms like Klarity Health connect Delaware residents with licensed psychiatric providers who can evaluate, diagnose, and prescribe anxiety medications online.

Psychiatric Medication Management

Medication management visits with a prescribing clinician for anxiety medications are typically covered under the mental health outpatient benefit. Prescriptions are filled through CVS/Caremark under the pharmacy benefit (see formulary details below).

Intensive Outpatient and Partial Hospitalization

For more severe anxiety presentations, Aetna plans may cover intensive outpatient programs (IOP, typically 3 hours/day, 3-5 days/week) and partial hospitalization programs (PHP). Prior authorization is generally required for these levels of care.

CVS/Caremark Anxiety Medication Formulary (Delaware, 2026)

Aetna uses CVS/Caremark as its pharmacy benefit manager. The following table shows how common anxiety medications are typically classified under CVS/Caremark’s formulary in Delaware. Tier placement, prior authorization (PA) requirements, controlled substance schedule, and Delaware EPCS status are shown. Always verify your specific plan’s formulary at CVS/Caremark.com or by calling 1-800-552-8159.

Tier placement and PA requirements shown are typical for CVS/Caremark standard formularies. Your specific Aetna plan may use a different formulary. Verify at CVS/Caremark.com or call 1-800-552-8159.

First-Line vs. Step Therapy

CVS/Caremark’s formulary design typically prioritizes first-line SSRIs and SNRIs, the medications with the strongest evidence base for GAD, panic disorder, and social anxiety disorder. Benzodiazepines and pregabalin may require step therapy demonstrating an inadequate response to an SSRI or SNRI before PA is approved. If your prescriber believes step therapy is clinically inappropriate for you, they may request a step therapy exception.

Delaware EPCS Requirements for Anxiety Medications

Delaware requires electronic prescribing of controlled substances (EPCS) under regulations promulgated by the Delaware Board of Medical Licensure (DE Admin Code, Title 24, § 1700). Delaware’s EPCS requirements apply to controlled substances in Schedules II through V.

What This Means for Anxiety Medications in Delaware

Benzodiazepines (Schedule IV). EPCS REQUIRED

Alprazolam (Xanax), clonazepam (Klonopin), lorazepam (Ativan), and diazepam (Valium) are Schedule IV controlled substances. In Delaware, prescriptions for these medications must be transmitted electronically via a certified EPCS system. Paper, oral, or fax prescriptions are not permitted except under narrow emergency exceptions.

Pregabalin/Lyrica (Schedule V). EPCS REQUIRED

Pregabalin is a Schedule V controlled substance at the federal level and in Delaware. Delaware EPCS applies to Schedule V, so pregabalin prescriptions must also be transmitted electronically.

SSRIs, SNRIs, Buspirone, Hydroxyzine, Propranolol. EPCS Inapplicable

These medications are not scheduled controlled substances. Delaware’s EPCS law does not apply to non-scheduled drugs. Prescribers may use any compliant prescribing method.

Telehealth and EPCS Compliance

Klarity Health’s licensed providers in Delaware use certified EPCS-compliant prescribing platforms. If your treatment plan requires a Schedule IV (e.g., short-term benzodiazepine) or Schedule V (pregabalin) medication, Klarity’s clinicians can prescribe these electronically in full compliance with Delaware EPCS requirements, subject to clinical appropriateness and applicable prescribing regulations.

Prior Authorization for Anxiety Medications: What to Expect

CVS/Caremark may require prior authorization (PA) for certain anxiety medications, particularly benzodiazepines and pregabalin. Common PA criteria include:

• Diagnosis confirmation: Documentation of an anxiety disorder diagnosis (GAD, panic disorder, social anxiety disorder, PTSD, OCD) from a licensed clinician
• Step therapy: For benzodiazepines and pregabalin, documentation of an adequate trial of a first-line SSRI or SNRI (typically 4-8 weeks at therapeutic dose)
• Quantity limits: Benzodiazepines often carry quantity limits (e.g., 30-day supply, limited refills) under CVS/Caremark formulary management and in accordance with clinical guidelines
• Prescriber information: Prescriber NPI, DEA number (for Schedule IV/V), and clinical notes supporting medical necessity

Your Klarity Health provider can submit PA documentation directly to CVS/Caremark and provide clinical notes supporting medical necessity for the prescribed medication.

How to Verify Your Aetna Anxiety Benefits in Delaware

Before starting anxiety treatment, take these steps to understand your Aetna coverage:

1. Call Aetna Member Services: Dial the number on the back of your insurance card or call 1-800-872-3862. Ask specifically: “Does my plan cover outpatient mental health/behavioral health visits? What is my copay, deductible, and out-of-pocket maximum for telehealth anxiety treatment?”
2. Check your Summary of Benefits and Coverage (SBC): Your SBC outlines your mental health cost-sharing at a glance. Find it at Aetna.com or in your enrollment documents.
3. Verify your CVS/Caremark formulary: Log in at CVS/Caremark.com or call 1-800-552-8159 to confirm your specific plan’s formulary tier for your anxiety medication and whether PA is required.
4. Confirm network status: Ask whether the provider you plan to see (in-person or telehealth) is in-network under your Aetna plan. Out-of-network costs can be substantially higher.
5. Request a benefits verification: Klarity Health’s intake team can help verify your Aetna benefits before your first visit.

How to Appeal a Denied Anxiety Treatment Claim with Aetna in Delaware

If Aetna denies a claim or prior authorization for anxiety treatment, you have the right to appeal. Delaware law establishes clear timelines and protections:

1. Written denial: Aetna must provide a written denial with the specific reason(s) and instructions for how to appeal.
2. Peer-to-peer review: Your prescriber or treating clinician can request a peer-to-peer conversation with Aetna’s medical director to discuss clinical necessity. This is often the fastest path to overturning a PA denial.
3. Formal internal appeal: File a written internal appeal with Aetna. Delaware law requires Aetna to decide within 30 days for non-urgent appeals and 72 hours for urgent/concurrent care appeals.
4. Parity complaint (§ 3343): If you believe the denial reflects a mental health parity violation. Applying stricter criteria to anxiety care than to comparable medical/surgical benefits. File a parity complaint with the Delaware Department of Insurance at 1-302-674-7300.
5. External independent medical review (IMR): If your internal appeal is upheld, you may request an external review by an Independent Review Organization (IRO) certified by the Delaware Department of Insurance. The IRO’s decision is binding on Aetna. For ERISA self-funded plans, contact the DOL EBSA at 1-866-444-3272.

Accessing Anxiety Treatment Through Klarity Health with Aetna in Delaware

Klarity Health connects Delaware residents with 2,000+ licensed providers, including psychiatric nurse practitioners and physicians who specialize in anxiety disorders. Klarity’s telehealth platform is designed to work with insurance, including Aetna plans in Delaware.

What Klarity offers for anxiety treatment:

• Initial psychiatric evaluation for GAD, panic disorder, social anxiety, PTSD, OCD, and related conditions
• Evidence-based medication management. SSRIs, SNRIs, buspirone, hydroxyzine, and other clinically appropriate options
• EPCS-certified prescribing for Schedule IV (benzodiazepines) and Schedule V (pregabalin) medications where clinically appropriate, in full compliance with Delaware law
• Ongoing follow-up visits for medication adjustments and progress monitoring
• Benefits verification assistance before your first visit

See If Your Aetna Plan May Cover Anxiety Treatment →

Frequently Asked Questions

Does Aetna cover therapy for anxiety in Delaware?

Many Aetna plans in Delaware may cover outpatient therapy for anxiety disorders, including in-person and telehealth sessions. The number of covered visits, copay, and deductible vary by plan. Call Aetna at 1-800-872-3862 to verify your specific behavioral health benefits.

Does CVS/Caremark require step therapy for anxiety medications?

CVS/Caremark’s formulary typically requires step therapy for benzodiazepines and pregabalin, meaning documentation of a prior adequate trial of an SSRI or SNRI. First-line SSRIs and SNRIs (sertraline, escitalopram, venlafaxine ER, duloxetine) generally do not require step therapy and are placed on low-cost Tier 1-2.

Can I get benzodiazepines prescribed online in Delaware through Klarity?

Delaware’s EPCS law requires that Schedule IV medications (including benzodiazepines) be prescribed electronically. Klarity’s providers use EPCS-certified systems and may prescribe benzodiazepines where clinically appropriate and legally permissible, subject to clinical evaluation and prescribing regulations.

Does Delaware’s parity law protect my anxiety treatment coverage?

Yes, for fully insured commercial Aetna plans in Delaware. Del. Code Ann. tit. 18, § 3343 requires mental health benefits, including anxiety treatment, to be no more restrictive than medical/surgical benefits. Self-funded ERISA employer plans are governed by federal MHPAEA instead.

What if Aetna denies my anxiety medication prior authorization?

Request a peer-to-peer review between your prescriber and Aetna’s medical director, then file a formal internal appeal if needed. If the denial appears to reflect a parity violation, file a complaint with the Delaware Department of Insurance at 1-302-674-7300. You also have the right to external independent medical review.

Is Klarity Health in-network with Aetna in Delaware?

Network status varies by Aetna plan and provider. Contact Klarity Health’s intake team to verify whether your specific Aetna plan covers Klarity providers in Delaware before booking.

Key Contacts

• Aetna Member Services: 1-800-872-3862
• CVS/Caremark Pharmacy Benefits: 1-800-552-8159
• Delaware Department of Insurance: 1-302-674-7300
• DOL EBSA (ERISA/MHPAEA complaints): 1-866-444-3272
• CMS: 1-800-633-4227

Coverage disclaimer: Insurance coverage for anxiety treatment varies by Aetna plan type, employer group, state, and individual benefit design. The information in this guide reflects typical Aetna and CVS/Caremark plan structures in Delaware as of 2026 and is provided for general informational purposes only. It is not a guarantee of coverage. Always verify your specific benefits with Aetna and CVS/Caremark before scheduling care or filling a prescription.